ACM
NRIX icon

ADAR1 Capital Management’s Nurix Therapeutics NRIX Stock Holding History

ADAR1 Capital Management’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$869K Sell
56,070
-16,000
-22% -$265K 0.05% 174
2025
Q4 		$1.37M Buy
72,070
+40,870
+131% +$587K 0.1% 118
2025
Q3 		$288K Hold
31,200
– – 0.03% 164
2025
Q2 		$355K Buy
31,200
+10,000
+47% +$108K 0.05% 133
2025
Q1 		$252K Buy
21,200
+10,200
+93% +$171K 0.05% 136
2024
Q4 		$207K Buy
+11,000
New +$252K 0.04% 156
2024
Q3 		– Sell
-3,500
Closed -$73K – 320
2024
Q2 		$73K Sell
3,500
-32,108
-90% -$500K 0.01% 181
2024
Q1 		$523K Buy
+35,608
New +$383K 0.12% 81

Other funds holding NRIX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return